Psycho-Babble Health | about physical health | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Has FDA swung the other way?

Posted by Christ_empowered on September 28, 2010, at 15:59:29 [reposted on October 1, 2010, at 5:27:21 | original URL]

In reply to Re: Has FDA swung the other way?, posted by linkadge on September 28, 2010, at 15:51:26

I just don't get why this drug was rejected. The FDA just approved Fanapt and Saphris for bipolar and schizophrenia, even though they're no better than other drugs already on the market and they have some pretty serious health risks (saphris, for instance, can cause death. DEATH.)

They approve a re-mix of dexedrine for ADHD. Now this stuff comes out for an under-served patient population, and they're like "Nope, abuse potential way too high--no can do." Where was this concern for the public when Xanax got approved? Or Bextra, Vioxx, etc.? Avandia?




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Health | Framed

poster:Christ_empowered thread:964355